View Older Stories View More Recent Stories
-
Pacira BioSciences to Participate in Fireside Chat at the 2023 RBC Capital Markets Global Healthcare Conference
-
Ionis to present at upcoming investor conferences
-
Enanta Pharmaceuticals to Participate in Two Investor Conferences in May
-
Verve Therapeutics to Participate in the RBC Capital Markets 2023 Global Healthcare Conference
-
T-Mobile (TMUS) to Sell $3.5B of Senior Notes
-
T-Mobile Agrees to Sell $3.5 Billion of Senior Notes
-
Palantir jumps on forecast for profit every quarter in 2023, AI demand
-
RBC Capital on Acadia Pharmaceuticals (ACAD): 'We see a -1-2% stock move off the Nuplazid slight miss for 1Q23'
-
Kenvue (KVUE) Announces Closing of IPO
-
Kenvue Announces Closing of Initial Public Offering
-
Tabula Rasa HealthCare Reports First Quarter 2023 Financial Results
-
HealthEquity Sets Date to Announce First Quarter Results Presentation at Conferences
-
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Conference Call and Webcast Today at 4:30 p.m. ET
-
Air Canada to Participate in Upcoming Investor Conferences
-
Cerevance to Present at the 2023 RBC Capital Markets Global Healthcare Conference
-
Bio-Rad to Participate in Fireside Chat During 2023 RBC Capital Markets Global Healthcare Conference
-
Pan American Silver Announces Completion of Successful Consent Solicitations with Respect to Yamana Gold Inc.’s 4.625% Senior Notes Due 2027 and 2.630% Senior Notes Due 2031
-
Elevance Health Announces Appearance at the 2023 RBC Capital Markets Global Healthcare Conference
-
Morphic Therapeutic Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
NextGen Healthcare to Participate in RBC Capital Markets Global Healthcare Conference
-
INOVIO to Present at the 2023 RBC Capital Markets Global Healthcare Conference
-
Lyft rattles Wall Street as margins suffer in race with Uber
-
Editas Medicine Announces First Quarter 2023 Results and Business Updates
-
Summit Midstream Partners, LP Reports First Quarter 2023 Financial and Operating Results
-
PBF Energy boosts buyback plan, beats Q1 on robust margins
-
eHealth, Inc. to Present at 2023 RBC Capital Markets Global Healthcare Conference on May 16th, to Host Investor & Analyst Day on May 18th
-
MindMed Reports First Quarter 2023 Financial Results and Business Highlights
-
Kellogg's pricing actions help bolster annual forecasts
-
Compass Minerals Appoints Jill Gardiner as Independent Director
-
Intellia Therapeutics Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
-
HOOKIPA Pharma to Participate in Upcoming Investor Conferences in May
-
Aptose to Participate in RBC Capital Markets 2023 Global Healthcare Conference
-
HF Sinclair's bid for Holly Energy overshadows profit beat, shares down
-
Kenvue (KVUE) Prices Upsized 172.18M Share IPO at $22/sh
-
Johnson & Johnson and Kenvue Announce Pricing of Upsized Kenvue Inc. Initial Public Offering
-
Callon Petroleum (CPE) to Acquire Core Delaware Basin Assets and Exit Eagle Ford
-
Callon to Acquire Core Delaware Basin Assets and Exit Eagle Ford
-
Brookdale to Present at the 2023 RBC Capital Markets Global Healthcare Conference
-
Thorne HealthTech to Participate in the 2023 RBC Capital Markets Global Healthcare Conference on May 16
-
Zynex, Inc. (ZYXI) Announces Proposed 2M Share Secondary Offering
-
Zynex Announces Proposed Secondary Public Offering of Common Stock
-
Flywire to Attend Upcoming Investor Conferences
-
Phillips 66 joins rivals to beat profit estimates as refining margins soar
-
R1 RCM to Present at Upcoming Investor Conferences
-
Jazz Pharmaceuticals to Participate in the 2023 RBC Capital Markets Global Healthcare Conference
-
Spruce Biosciences to Participate in May Investor Conferences
-
Morphic Therapeutic (MORF) Announces Proposed Public Offering
-
Morphic Therapeutic Announces Proposed Public Offering
-
Acadia Pharmaceuticals to Present at Upcoming Investor Conferences
-
Emera Issues $500 Million Principal Amount of Senior Unsecured Notes Due May 2, 2030

